Komori
Earnings4881FunPep Company LimitedPharmaceuticals

Summary of Financial Results for the First Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated)

First-quarter revenue was unchanged year on year at ¥0 million, while the operating loss narrowed from ¥603 million to ¥294 million and the quarterly net loss attributable to owners of the parent narrowed from ¥598 million to ¥291 million, mainly due to lower business expenses. The full-year earnings forecast has not been disclosed due to uncertainty.

Worth reading
30Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
309
¥ million
Wording
Avoiding a definitive answer
How definitive the wording is.

Results for this period

First quarter1 January 2026–31 March 2026ConsolidatedJapanese GAAP
Net Sales0¥ millionYear on year 0.0%
Operating profit-294¥ million
Ordinary income-290¥ million
Net income attributable to owners of the parent-291¥ million

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.

Net income per share-¥7.03
Financial position at period-end
Total assets2,053¥ million
of which net assets 1,591 ¥ millionEquity ratio 76.1%vs. prior year-end +3.4pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Outlook and shareholder returns
Annual Dividend Forecast¥0 → ¥0(0.0%)
Factors Behind Changes in Business Performance

Business expenses decreased by ¥309 million from the same quarter of the previous year to ¥294 million. Research and development expenses decreased by ¥306 million due to lower development costs for FPP004X, while other selling, general and administrative expenses decreased by ¥2 million.

Disclosure regarding the going concern assumption

No applicable matters ("There are no applicable matters")

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name None
Depreciation and amortization¥224 thousand
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNone (対象者:Not applicable)
Issued Shares at Period-End44,846,700 shares
Treasury Shares at Period-End12 shares
Results for this period
ItemDetails
Fiscal Period ClassificationFirst quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 January 2026–31 March 2026
Net Sales¥0 million (YoY 0.0%)
Operating profit¥-294 million
Ordinary income¥-290 million
Profit attributable to owners of the parent¥-291 million
Net income per share-¥7.03
Equity ratioEnd of the current fiscal period 76.1% / End of previous period 72.7%
Total assets¥2,053 million
Net assets¥1,591 million
Annual Dividend Forecast¥0 → ¥0(0.0%)
Depreciation and amortization¥224 thousand
Disclosure regarding the going concern assumptionNo applicable matters ("There are no applicable matters")
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name None
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNone (対象者:Not applicable)
Issued Shares at Period-End44,846,700 shares
Treasury Shares at Period-End12 shares
Factors Behind Changes in Business PerformanceBusiness expenses decreased by ¥309 million from the same quarter of the previous year to ¥294 million. Research and development expenses decreased by ¥306 million due to lower development costs for FPP004X, while other selling, general and administrative expenses decreased by ¥2 million.
Items this document does not state (16)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodFull-year earnings forecastRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossBreakdown of extraordinary income (loss)Material subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Business expenses decreased by ¥309 million year on year. The main factor was a ¥306 million decrease in research and development expenses due to lower development costs for FPP004X; other selling, general and administrative expenses also decreased by ¥2 million.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the First Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated) | FunPep Company Limited (4881) timely disclosure | Komori